Uroplasty (UPI) gets an upgrade to Market Outperform from JMP (price target $5.50). See analyst...
Uroplasty (UPI) gets an upgrade to Market Outperform from JMP (price target $5.50). See analyst Jose Haresco's Q&A with management on the latest CC (transcript).
From other sites
at Benzinga.com (Dec 29, 2014)
at Benzinga.com (Dec 22, 2014)
at MarketWatch.com (May 25, 2012)
at MarketWatch.com (May 5, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs